PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY, USA.\', \'Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.\', \'Department of Laboratory Medicine, Division of Pathology and Laboratory Medicine, University of Texas/MD Anderson Cancer Center, Houston, TX, USA.\', \'Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.\', \'Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, SC, USA.\', \'Departments of Biochemistry and Laboratory Medicine and Pathobiology, The Hospital for Sick Children/University of Toronto, Toronto, ON, Canada.\', \'Department of Pathology, University of Utah, ARUP Laboratories, Salt Lake City, UT, USA.\', \'Department of Clinical Microbiology, University of Rochester Medical Center, Rochester, NY, USA.\', \'LifeLabs Medical Laboratories, Toronto, ON, Canada.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1093/clinchem/hvab051
?:doi
?:hasPublicationType
?:journal
  • Clinical chemistry
is ?:pmid of
?:pmid
?:pmid
  • 34470034
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.281
?:rankingScore_hIndex
  • 195
?:title
  • AACC Practical Recommendations for Implementing and Interpreting SARS-CoV-2 Emergency Use Authorization and Laboratory-Developed Test Serologic Testing in Clinical Laboratories.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all